Ahmedabad, India (CU)_ Cadila Pharmaceuticals, headquartered in Ahmedabad, has developed a unique three-dose rabies G protein vaccination using recombinant nanoparticles. Additionally, a campaign titled…

Cadila Pharma introduces a revolutionary three-dose rabies vaccine

Nat Sciver-Brunt’s Journey from Tokyo to England Captain: How a World-Class All-Rounder Became a Cricket Icon

The Jet That Shrunk the Pacific: Singapore Airlines’ Airbus A350 Strategy Changed the Future of Asia–US Travel

Macbeth: How One Prophecy Unleashed a Storm of Ambition, Murder and Madness

Trump’s New 50% Canada Tariffs: What the U.S. Trade Move Means for Canadian Exports and Businesses

18-Year-Old Seine Stowers Becomes Samoa’s New Weightlifting Hero After 12 Records and Four Gold Medals

Related Articles

New Ultrasound Procedure Successfully Targets Twin-Twin Transfusion Syndrome Without Surgery

Could Artificial Sweeteners Be Slowing the Growth of Healthy Gut Bacteria?

India’s First Dengue Vaccine Approved as QDENGA Gains DCGI Approval

Feeling Lonely Often? Scientists Uncover the Mental Health Risks of Loneliness

New Malaria Drug Candidate MMV367 Shows Rapid Parasite Killing and Hope Against Drug Resistance

BRICS expansion: five countries join, another 25 to follow in 2024

Chinese state media lauds India’s achievements under PM Modi!

Security alarm for India: Bangladesh frees Al-Qaeda terror group chief